Abstract:Background: Long noncoding RNAs have been shown to play crucial roles in cancer biology, while the long noncoding RNA landscapes of pancreatic ductal adenocarcinoma have not been completely characterized. We aimed to determine whether long noncoding RNA could serve as early diagnostic biomarkers for pancreatic ductal adenocarcinoma. Method: We conducted a genome-wide microarray analysis on pancreatic ductal adenocarcinoma and their adjacent noncancerous tissues from 8 Chinese patients. Results: A total of 3352 significantly differentially expressed long noncoding RNAs were detected. Of total, 1249 long noncoding RNAs were upregulated and 2103 were downregulated (fold change >= 2, P < 0.05, FDR <0.05). These differentially expressed long noncoding RNAs were not evenly distributed among chromosomes in human genome. Hierarchical clustering of these differentially expressed long noncoding RNAs revealed large variabilities in long noncoding RNA expression among individual patient, indicating that certain long noncoding RNAs could play a unique role or be used as a biomarker for specific subtype of pancreatic ductal adenocarcinoma. Gene Ontology enrichment and pathway analysis identified several remarkably dysregulated pathways in pancreatic ductal adenocarcinoma tissue, such as interferon-g-mediated signaling pathway, mitotic cell cycle and proliferation, extracellular matrix receptor interaction, focal adhesion, and regulation of actin cytoskeleton. The co-expression network analysis detected 393 potential interactions between 80 differentially expressed long noncoding RNAs and 105 messenger RNAs. We experimentally verified 7 most markedly dysregulated long noncoding RNAs from the network. Conclusion: Our study provided a genome-wide survey of dysregulated long noncoding RNAs and long noncoding RNA/messenger RNA co-regulation networks in pancreatic ductal adenocarcinoma tissue. These dysregulated long noncoding RNA/messenger RNA networks could be used as biomarkers to provide early diagnosis of pancreatic ductal adenocarcinoma or its subtype, predict prognosis, and evaluate treatment efficacy.

Long Non-Coding RNAs Expressed in Pancreatic Ductal Adenocarcinoma and Lncrna BC008363 an Independent Prognostic Factor in PDAC.

The oncogenic potentials and diagnostic significance of long non-coding RNA LINC00310 in breast cancer.

LINC00346 Promotes Pancreatic Cancer Progression Through the CTCF-mediated Myc Transcription

Analysis of Long Non-Coding RNA Expression Profiles in Pancreatic Ductal Adenocarcinoma

The expression and clinical significance of the long non-coding RNA-BC043614 in pancreatic ductal adenocarcinoma

Microarray Expression Profile Analysis of Long Non-Coding RNAs in Pancreatic Ductal Adenocarcinoma.

A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma.

Overexpression of a Long Non-Coding RNA BC037916 is Associated with Pancreatic Tumorigenesis and Poor Prognosis.

Genome-Wide Analysis Identified a Number of Dysregulated Long Noncoding RNA (lncRNA) in Human Pancreatic Ductal Adenocarcinoma.

Integrated Analysis of Long Non-Coding RNA and Mrna Expression Profile in Pancreatic Cancer Derived Exosomes Treated Dendritic Cells by Microarray Analysis

Systemic Analyses of Cuproptosis-Related Lncrnas in Pancreatic Adenocarcinoma, with a Focus on the Molecular Mechanism of LINC00853

Next-generation Sequencing Reveals Novel Differentially Regulated Mrnas, Lncrnas, Mirnas, Sdrnas and a Pirna in Pancreatic Cancer

Identification of key lncRNAs in the tumorigenesis of intraductal pancreatic mucinous neoplasm by coexpression network analysis

A Novel and Robust Long Noncoding RNA Panel to Predict the Prognosis of Pancreatic Cancer

Exploring the Wnt Pathway-Associated LncRNAs and Genes Involved in Pancreatic Carcinogenesis Driven by Tp53 Mutation

Construction and Integrated Analysis of a Lncrna-Associated Competing Endogenous RNA Network Reveal Functional Lncrnas in Pancreatic Cancer

The C/Ebp Beta-Linc01133 Axis Promotes Cell Proliferation In Pancreatic Ductal Adenocarcinoma Through Upregulation Of Ccng1

RETRACTED ARTICLE: Long noncoding RNA LINC00657 enhances the malignancy of pancreatic ductal adenocarcinoma by acting as a competing endogenous RNA on microRNA-433 to increase PAK4 expression

Genome-wide RNA-sequencing dataset reveals the prognostic value and potential molecular mechanisms of lncRNA in non-homologous end joining pathway 1 in early stage Pancreatic Ductal Adenocarcinoma

Five Key Lncrnas Considered As Prognostic Targets for Predicting Pancreatic Ductal Adenocarcinoma

The Biological Function Delineated Across Pan-Cancer Levels Through lncRNA-Based Prognostic Risk Assessment Factors for Pancreatic Cancer